Google changes its search box for the first time in 25 years

Google is overhauling its search box for the first time since 2001, making it larger and more interactive to support longer AI-driven queries, image/video uploads, follow-up chatbot questions, and agent-based automated searches powered by Gemini 3.5 Flash. Separately, the article notes a TrumpRx expansion to more than 600 generic drugs, a study finding deportations hurt employment in affected industries, a stock-trading disclosure involving Trump, a Spain homicide investigation involving Mango's founder's son, and an EPA review clearing atrazine for continued use.

Analysis

The strategic read-through is that Google is shifting Search from a destination page to an AI operating layer, which raises the bar for every consumer internet company monetizing intent. A larger, more conversational box plus multimodal inputs should increase query complexity and session depth, but the bigger economic implication is that Google is trying to intercept more of the “research-to-action” chain before users reach downstream vertical sites. That is structurally negative for lead-gen and comparison-shopping intermediaries, while still supportive of Google because higher engagement can offset any near-term monetization friction.

The more important second-order effect is on customer acquisition costs across housing, travel, shopping, and local services. If agents start capturing recurring tasks like listing alerts or email triage, then traffic that used to be paid for once per conversion may become owned by the platform, compressing margins for vertical marketplaces over the next 6-18 months. This is not yet a revenue shock; it is a gradual mix shift risk that will show up first in click-through economics, then in partner bargaining power.

For semis, the model economics matter more than the feature set: a cheaper, faster Gemini widens the range of use cases Google can deploy at scale, which increases inference intensity even if unit cost falls. That makes NVDA’s medium-term demand less about a single flagship product and more about aggregate query expansion and agentic workflows. The contrarian view is that investors may be underestimating how quickly AI search can improve Google’s monetization per query; if users interact more, Google can offset lower ad load with better intent matching and higher conversion rates.

Policy and labor headlines are more of a background factor than a direct market mover, but the deportation data suggests a mild negative for labor-intensive domestic cyclicals over the next several quarters, especially construction and select industrials. On the drug-pricing side, TrumpRx’s generic expansion is incrementally positive for consumer affordability but likely pressureless for the big branded names because the platform is a referral layer, not a true distribution moat. The atrazine decision is a tailwind for incumbent ag inputs and a reminder that regulatory risk can swing back toward incumbents when the administration prioritizes supply stability over environmental constraints.

Key Decisions for Investors

• Add to GOOGL on 3-6 month horizon; use a buy-the-dip approach on any post-event weakness. Risk/reward is favorable because AI search expansion should support engagement and monetization, while the market still discounts distribution cannibalization risk.
• Initiate a pair trade: long GOOGL / short a basket of vertical intent platforms and lead-gen exposed names over the next 6-12 months. The thesis is Google internalizing more high-value queries and reducing outbound traffic to third-party comparison sites.
• Stay long NVDA on a 6-12 month view, but size it as an infrastructure demand trade rather than a product-cycle trade. Best entry is on any pullback tied to fears of lower AI inference costs; cheaper models can increase total usage faster than they compress demand.
• Underweight or hedge housing/construction-exposed equities for the next 2-4 quarters. The deportation data points to a quieter labor-availability headwind that can pressure project timelines and margins before it shows up in headline employment data.
• Watch GDRX only as a tactical beneficiary, not a core long. The TrumpRx expansion improves discovery and coupon flow, but the model remains a funnel business with limited pricing power; use rallies to sell into strength rather than chase.